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-1.5), reducing overbite (MD -2.5; 95% CI -3.2 to -1.8), reducing mandibular crowding (RR 0.4; 95% CI
0.2-0.8) and establishing Class I canine relationship (RR = 2.3; 95% CI 1.1-4.9). However, compared
to custom-made functional appliances, three trials indicated that PMAs were less effective in reducing
the ANB angle (MD 0.9; 95% CI 0.5-1.4), increasing mandibular ramus length (MD -2.2; 95% CI -2.9 to
-1.51), reducing overjet (MD 1.5; 95% CI 0.9-2.1), establishing a solid Class I molar relationship (RR 0.3;
95% CI 0.2-0.7), reducing the nasolabial angle (MD 5.8; 95% CI 0.8-10.8) and reducing facial convexity
(MD -2.6; 95% CI -4.3 to -0.9). Finally, the quality of evidence was moderate to low due to risk of
bias. Conclusions: PMAs are more effective in reducing overjet, overbite, mandibular crowding and es-
tablishing Class I canine relationship than no treatment. However, compared to custom-made functional
appliances, PMAs are less effective in producing dental, skeletal or soft-tissue changes, even though
they are less costly. Keywords: Class II malocclusion; evidence-based medicine; functional appliance;
malocclusion; meta-analysis; myofunctional therapy; randomised trial; systematic review.
DOI: https://doi.org/10.1177/1465312519880558





Papageorgiou, Spyridon N; Koletsi, Despina; Eliades, Theodore (2019). What evidence exists for my-
ofunctional therapy with prefabricated appliances? A systematic review with meta-analyses of randomised




What evidence exists for myofunctional therapy with prefabricated appliances? A 
systematic review with meta-analyses of randomised trials 
 
Spyridon N. Papageorgiou1, Despina Koletsi1, Theodore Eliades1 
 
1 Clinic of Orthodontics and Pediatric Dentistry, Center of Dental Medicine, University of Zurich, Zurich, 
Switzerland 
 
Corresponding author: Spyridon N. Papageorgiou, Clinic of Orthodontics and Pediatric Dentistry, Center 
of Dental Medicine, University of Zurich, Plattenstrasse 11, Zurich, Switzerland; snpapage@gmail.com. 
 
ORCIDs: S.N. Papageorgiou: 0000-0003-1968-3326 / D. Koletsi: 0000-0001-6280-9372 / T. Eliades: 
0000-0003-2313-4979 
 
Short title: Clinical evidence on myofunctional appliances 
Conflicts of interest: None. 
Funding: none. 
Acknowledgements: We would like to thank Dr. A.F. Hanoun (Plano, TX) for providing a copy of his 
unpublished master thesis. 
Words in abstract: 250 




Objective: To assess the treatment efficacy/efficiency with Prefabricated Myofunctional Appliances (PMA) 
for children with malocclusion. 
Data sources: Nine databases searched without limitations till July 2019. 
Data selection: Randomised trials comparing PMAs to functional appliance treatment or no treatment. 
Data extraction: Study selection, data extraction, and risk of bias assessment were done in duplicate.  
Data synthesis: Random-effects meta-analyses of Mean Differences (MDs) or Relative Risks (RRs) with 
their 95% Confidence Intervals (CIs) were conducted on seven publications (3 published and 1 unpublished 
trials; 232 patients; 53% male; mean age 10.2 years). Compared to no treatment, one trial indicated that 
PMAs were somewhat effective in reducing overjet (MD=-2.4; 95% CI=-3.3, -1.5), reducing overbite (MD=-
2.5; 95% CI=-3.2, -1.8), reducing mandibular crowding (RR=0.4; 95% CI=0.2,0.8), and establishing Class 
I canine relationship (RR=2.3; 95% CI=1.1,4.9). However, compared to custom-made functional 
appliances, 3 trials indicated that PMAs were less effective in reducing the ANB angle (MD=0.9; 95% 
CI=0.5, 1.4), increasing mandibular ramus length (MD=-2.2; 95% CI=-2.9, -1.51), reducing overjet (MD=1.3; 
95% CI=0.6, 2.0), establishing a solid Class I molar relationship (RR=0.3; 95% CI=0.2, 0.7), reducing the 
nasolabial angle (MD=5.8; 95% CI=0.8, 10.8), and reducing facial convexity (MD=-2.6; 95% CI=-4.3, -0.9). 
Finally, the quality of evidence was moderate to low due to risk of bias.  
Conclusions: PMAs are more effective in reducing overjet, overbite, mandibular crowding, establishing 
Class I canine relationship than no treatment. However, compared to custom-made functional appliances, 
PMAs are less effective in producing dental, skeletal, or soft-tissue changes, even though they were less 
costly. 
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The interplay between soft tissue pressure from abnormal lip / tongue function, habits or respiratory 
problems and craniofacial development have been well documented and reported many decades ago 
(Moss and Rankow, 1968; Moss, 1997]. As a result, much attention has been paid to control the dentofacial 
growth by correcting oral dysfunction and establishing oral muscular balance (Owman-Moll and Ingervall, 
1984). 
Oral myofunctional therapy was introduced primarily by Rogers in the early 1900s (Cottingham, 
1976), and was based on exercises aiming to establish proper oral function that would be compatible with 
good occlusion. A recent systematic review of however indicated that there is a lack of high-quality evidence 
in the existing literature regarding early orthodontic management and orofacial muscle training protocols 
on the correction of myofunctional and myoskeletal problems in the developing dentition (Koletsi et al., 
2018). It is also important to note that Rogers considered myofunctional exercises as an aid in treatment 
and retention (Proffit and Mason, 1975) and not as a universal therapeutic approach for all orthodontic 
problems (Wishney et al., 2019).  
Apart from orofacial muscle training exercises, myofunctional therapy has also including various 
myofunctional appliances, since the initial introduction of the oral screen in 1912 (Idris et al., 2018). Such 
myofunctional appliances include Prefabricated Myofunctional Appliances (PMA) like the oral shield 
(Cheney, 1958; Cheney, 1963), the double oral screen (Rossi et al., 1984), the Eruption Guidance 
Appliance (Bergersen, 1984), LM-ActivatorTM, Myobrace®, Trainer for Kids™, and Occluso-Guide®. 
Common therapeutic protocols suggest that treatment with PMAs should be accompanied by myofunctional 
exercises as a part (Quadrelli et al., 2002; Tallgren et al., 1998). Some observational studies have shown 
that treatment with PMAs can influence oral muscle activity (Tallgren et al., 1998), reduce overjet (Tallgren 
et al., 1998; Quadrelli et al., 2002; Usumez et al., 2004), increase the SNB angle (Usumez et al., 2004), 
and increase facial height (Usumez et al., 2004). However, these studies presented several methodological 
limitations, including lack of an a priori registered protocol, lack of randomised treatment allocation, lack of 
allocation concealment, inappropriate control groups, lack of blinding, small-study effects, and reporting 
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biases (Papageorgiou et al., 2014; Papageorgiou et al., 2015a; Papageorgiou et al., 2015b; Koretsi et al., 
2017; Papageorgiou et al., 2018; Papageorgiou et al., 2019a). 
On the other hand, randomised clinical trials in recent years (Myrlund et al., 2015; Cirgic et al., 
2016; Idris et al., 2018) indicate that initial findings from observational studies or marketing claims made by 
manufacturers of PMAs might not be true. A recent systematic review of randomised and non-randomised 
studies (Mohammed et al., 2019) found that PMAs were less effective in reducing overjet of patients with 
Class II malocclusion in the short-term compared to custom-made Activators, but this effect was diminished 
in the long-term. Also, PMAs were associated with reduced costs compared to custom-made Activators. 
However, the inclusion of non-randomised studies might have introduced bias (Papageorgiou et al., 2015a; 
Papageorgiou et al., 2015b). Additionally, the clinical relevance of dental, skeletal or soft-tissue effects of 
PMAs on growing children needs to be assessed both in terms of absolute efficacy compared just to 
physiological growth, as well as in terms of relative efficacy compared to functional appliances, which are 




Aim of this systematic review was to critically appraise existing evidence from randomised trials supporting 
the use of PMAs for the treatment of malocclusions in children compared to other interventions or untreated 
controls. 
 
2. Materials and methods 
2.1. Protocol and registration 
The review’s protocol was registered a priori (https://osf.io/v3pjr/) and all post hoc changes were noted 
(Appendix 1). This review was conducted and reported according to the Cochrane Handbook (Higgins and 
Green, 2011) and PRISMA statement (Liberati et al., 2009), respectively. 
 
2.2. Eligibility criteria 
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According to the Participants-Intervention-Comparison-Outcome-Study design schema, included were 
parallel randomised clinical trials assessing the clinical performance of PMAs administered at healthy 
children of any sex, ethnicity, or malocclusion compared to functional appliances treatment or no treatment. 
No limitations concerning language, publication year, or publication status were applied. Excluded were 
non-randomised studies, case series/reports, animal studies, non-longitudinal studies, non-clinical studies, 
animal studies, and studies on children with systemic diseases, obstructive sleep apnoea, or receiving 
surgery. 
 
2.3. Information sources and literature search 
A total of nine electronic databases were searched systematically without any limitations from inception up 
to July 25th, 2019 (Appendix 2). In addition, Directory of Open Access Journals (DOAJ), Digital 
Dissertations (searched via UMI ProQuest), metaRegister of Controlled Trials, and Google Scholar were 
manually searched for additional trials. Finally, the reference/citation lists of eligible articles, as well as the 
reference lists of relevant reviews were checked for additional trials.  
 
2.4. Study selection 
Two authors (SNP, DK) screened the titles and/or abstracts of studies retrieved from the searches to identify 
those potentially meeting the inclusion criteria. The full text of potentially eligible trials was assessed by two 
authors (SNP, DK), while a third author (TE) was consulted for consensus in case of discrepancies. 
 
2.5. Data collection and data items 
Data collection was conducted by two authors (SNP, DK) using pre-defined forms covering: (i) study 
characteristics (design, clinical setting, country), (ii) patient characteristics (age, sex), (iii) malocclusion 
details, (iv) appliance used and any myofunctional training exercises, (v) status of treatment provider, (vi) 
patient compliance through treatment, (v) follow-up, and (vi) outcomes measured. Discrepancies between 
assessors were resolved like above, while data not provided in the article were calculated or requested 
from trialists (Appendix 1). 
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2.6. Risk of bias in individual trials 
The risk of bias within included trials was assessed with the new Cochrane Risk Of Bias (ROB) 2.0 tool 
(Sterne et al., 2019) by two authors (SNP, DK) with the same way to resolve discrepancies. 
 
2.7. Outcomes and data synthesis 
As the outcome of early malocclusion treatment can be affected by patient characteristics (age, growth 
stage, malocclusion type/severity), the type of appliance, the patient’s compliance, and the patient’s 
individual growth potential, a random-effects model was deemed appropriate to calculate the average 
distribution of true effects, based on clinical and statistical reasoning (Papageorgiou, 2014a). A restricted 
maximum likelihood random effects model was chosen a priori, based on recent guidance (Langan et al., 
2019). Mean differences (MDs) for continuous outcomes and relative risks (RRs) for binary outcomes and 
their corresponding 95% confidence intervals (CIs) were chosen as effect sizes, while statistically significant 
RRs were translated into Numbers Needed to Treat (NNTs) to gauge their clinical relevance. 
Between-study heterogeneity was assessed by inspecting the forest plots and by calculating the τ2 
(absolute heterogeneity) and the I² statistics (relative heterogeneity). I2 defines the proportion of total 
variability in the result explained by heterogeneity, but not chance. We considered arbitrarily I² over 75% to 
represent considerable heterogeneity, while also considering the heterogeneity’s direction (localisation on 
the forest plot) and uncertainty intervals around heterogeneity estimates (Higgins et al., 2003). Ninety-five 
per cent predictive intervals were calculated for meta-analyses of ≥3 trials to incorporate existing 
heterogeneity and provide a range of possible effects for a future clinical setting (IntHout et al., 2016). 
All analyses were run in Stata version 14.0 (StataCorp LP, College Station, TX) by one author 
(SNP) and the dataset was openly provided (Papageorgiou et al., 2019b). All P values were two-sided with 
α=5%. 
 
2.8. Additional analyses, risk of bias across studies, and quality of evidence 
Possible sources of heterogeneity were a priori planned to be sought through subgroup analyses and 
random-effects meta-regression in meta-analyses of at least 5 trials but could ultimately not be performed 
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(Appendix 1). Likewise, reporting biases were planned to be assessed in meta-analyses of at least 10 trials, 
but could ultimately not, due to the limited number of meta-analysed trials. 
The overall quality of meta-evidence (i.e. the strength of clinical recommendations) was rated using 
the Grades of Recommendations, Assessment, Development, and Evaluation (GRADE) approach, as very 
low, moderate, or high (Guyatt et al., 2011) and Summary of Findings tables were constructed using the 
improved format proposed by Carrasco-Labra et al. (2016). The minimal clinical important, large, and very 
large effects were defined as half, one, and two standard deviations of the pre-treatment measurement (for 
continuous outcomes) and RRs of 1.5, 2.0, and 5.0 (for binary outcomes) (Norman et al., 2003; 
Schünemann et al., 2009). The produced forest plots were augmented with contours denoting the 
magnitude of the observed effects (Papageorgiou, 2014b) to assess heterogeneity, clinical relevance, and 
imprecision. 
 
2.9. Sensitivity analyses 
Robustness of the results was planned to be checked a priori with sensitivity analyses based on (i) 
inclusion/exclusion of trials with low risk of bias, (ii) improvement of the GRADE classification, and (iii) 
inclusion/exclusion of large trials (arbitrarily set as trials with at least 30 patients/group).  
 
3. Results 
3.1. Study selection 
The electronic literature search yielded 187 results, while 5 more were identified manually (Fig 1). After 
removal of duplicates and screening of titles / abstracts,  a total of 58 articles had their full text checked 
against the eligibility criteria. From these 5 journal papers, one doctoral dissertation, and one master’s 
thesis, all published in English between 2010-2018, were considered eligible for inclusion. As three papers 
and the doctoral dissertation pertained to the same trial, a total of 4 unique trials were finally included in 
this review (Appendix 3). Three included studies were published as journal papers (one also as doctoral 
dissertation), while a still unpublished master thesis was provided upon request (Appendix 1). 
 
3.2. Study characteristics 
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The characteristics of the 4 included trials are presented in Table 1. Three single-centre trials were 
conducted in orthodontic university clinics in Malaysia, Norway, or Syria, while a multi-centre trial was 
conducted in twelve general dental practices in Sweden. Three of the included trials compared PMAs to 
functional appliances, while the fourth trial compared PMAs to an untreated control group. These 4 trials 
included 124 patients treated with PMAs (range 16-57; average 31) and 108 patients treated with functional 
appliances or left untreated (range 17-40; average 27). Male patients constituted the 53% of all included 
patients (123/232) and had an overall mean age of 10.2 years. Patients included in the identified trials had 
mostly of Class II or Class I malocclusion with increased overjet, lip incompetence, overbite, crowding, and 
residual growth. The used PMAs included Myobrace® (Myofunctional Research Co, Australia), Trainer For 
Kids® (T4K or T4F, Myofunctional Research Co, Australia), or LM-Activator (LM-Instruments Oy, Finland), 
while the used functional appliances included Activator or Twin Block. Treatment was provided by 12 
general dentists in the multi-centre trial from Sweden, while orthodontic specialists or orthodontic residents 
under supervision by orthodontic specialist treated patients in the remaining 3 trials. Assessment of patient 
compliance with the appliances was reported only in two instances: in one case directly through patient 
interview or notes and in one case indirectly through treatment discontinuation or failure. Patients were 
followed after appliance administration for 6 months (1 trial), 12 months (2 trials), or for an undescribed 
period until treatment success or failure, ranging from 3.6 to 40.3 months (1 trial). Two trials assessed 
outcomes from dental casts, two from lateral cephalograms, and one assessed clinical efficacy/efficiency 
aspects (including time and costs). 
 
3.3. Risk of bias within studies 
The risk of bias of included studies is given in detail in Appendix 4 and as summary in Table 2. The single 
trial comparing PMAs to no treatment presented only some concerns that pertained to possible baseline 
imbalances and the lack of an a priori registered protocol. The three trials comparing PMAs to functional 
appliance all presented high risk of bias for at least one domain. The single-centre trial from Malaysia was 
scored as presenting some concerns mainly due to the potential issues with the reported results and the 
documented analysis plan. The multi-centre trial from Sweden was scored negatively for issues in the 
randomisation process/baseline similarity, deviations from the intended intervention, lack of blind outcome 
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measurement, lack of an a priori registered protocol, and issues with the analysis/reporting of its results. 
Finally, the single-centre trial from Syria lacked blind outcome measurement and an a priori registered 
protocol. 
 
3.4. Results of individual studies and data synthesis 
The results of identified studies are presented separately for the comparison of PMA (LM-Activator®) versus 
no treatment (absolute efficacy) and separately for the comparison of various PMAs (Myobrace® or Trainer 
for Kids®) versus functional appliances (relative efficacy). 
 As far as absolute effects of PMAs are concerned, only one included trial provided evidence on 
their efficacy based on analysis of dental casts (Table 3). This indicated that a 12-month treatment with 
PMAs was successful in reducing overjet (MD: -2.4 mm; 95% CI: -3.3 to -1.5 mm; P<0.001) and overbite 
(MD: -2.5 mm; 95% CI: -1.8 mm; P<0.001) to a statistically and clinically relevant degree compared to no 
treatment. Additionally, treatment with PMAs was associated with greater percentage of patients (63% 
versus 30%) with Class I canine relationship (RR: 2.3; 95% CI: 1.1 to 4.9; P=0.03) compared to no 
treatment. Using the NNT, this can be interpreted as every 4th patient treated with PMA having a Class I 
canine relationship after 12 months that would not have if left untreated. Interestingly, no such significant 
benefit was seen for Class I molar relationship (P=0.16). Furthermore, treatment with PMAs was associated 
with less patients having crowding in the mandible (25% versus 60%) compared to no treatment (RR: 0.4; 
95% CI: 0.2 to 0.8; P=0.02). According to the NNT, this meant that every 3rd PMA patient would avoid a 
mandibular crowding that would exist if the patient was left untreated.  
 As far as relative effects of PMAs against functional appliances are concerned, three trials were 
identified and could contribute to meta-analyses (Table 4). Treatment with PMAs was associated with 0.9° 
less ANB reduction (2 trials; 95% CI: 0.5 to 1.4°; P<0.001), 1.0° less SNB increase (2 trials; 95% CI: -1.6 
to -0.4°; P=0.001), 1.5 mm less overjet reduction (95% CI: 0.9 to 2.1 mm; P<0.001), and 1.4 less ANS-Me 
increase (2 trials; 95% CI: -2.5 to -0.3°; P=0.01) compared to functional appliances. All meta-analyses were 
homogenous (I2=0%) and the magnitude of the effects was mostly small to moderate (Fig 2-3). No 
significant differences could be found for changes in overbite, SNA, SN-ML, NL-ML, N-Me, 1s-NL, 1i-ML, 
and 1s-1i. 
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Apart from these meta-analyses, 37 more outcomes were assessed by single trials and are 
presented in Table 5, from which only results that are both statistically significant at 5% and potentially 
clinically relevant are discussed here. Treatment with PMAs was associated (compared to functional 
appliances) with smaller Condylion-Gonion distance (+0.5 and +2.7 mm, respectively; MD: -2.2 mm; 95% 
CI: -2.9 to -1.5 mm), smaller facial convexity angle (0 and +2.6°, respectively; MD: -2.6°; 95% CI: -4.3 to -
0.9°), and smaller nasolabial angle (+1.8 and -4.0°, respectively; MD: 5.8°; 95% CI: 0.8 to 10.8°). 
Additionally, treatment with PMAs was associated with smaller percentage of patients with Class I molar 
relationship post-treatment (14% versus 45%; Fig 4) compared to functional appliances (RR: 0.3; 95% CI: 
0.2 to 0.7). Using the NNT this means that for every 4th child treated with functional appliances instead of 
PMAs a Class I molar relationship is achieved, which would not be achieved if the child had been treated 
with PMAs. On the other hand, treatment with PMAs was associated with less visits (MD: -3.1 visits; 95% 
CI: -4.6 to -1.5 visits), less chair-time (MD: -78.0’; 95% CI: -113.5 to -42.5’), and less costs (MD: -574.0 €; 
95% CI: -774.6 to -373.5 €) compared to functional appliances.  
 
3.5. Risk of bias across studies, quality of evidence, and additional analyses 
As only a couple of trials could be ultimately included in meta-analyses, no subgroup analyses, meta-
regression analyses, or reporting bias analyses could be performed (Appendix 1). 
 The quality of existing evidence (i.e. the strength of clinical recommendations that can be 
formulated) was assessed with the GRADE approach (Table 6). Moderate quality of evidence supported 
the advantage of PMAs in terms of reduced costs and the disadvantages of PMAs in terms of worse occlusal 
(Class I molar relationship), skeletal (ANB angle and Cd-Go distance), and soft-tissue facial outcomes 
(facial convexity). This means that we can be fairly certain that the true effect is probably close to the 
estimated effect. On the other hand, low quality evidence supported the disadvantage of PMAs in terms of 
overjet reduction, which means that the true effect might be markedly different from the estimated effect 
and future studies might change this. 
Sensitivity analyses according to bias or improvement of GRADE could likewise not be performed, 
since all trials presented some risk of bias and this was the reason for downgrading the quality of evidence. 
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Only one sensitivity analysis according to sample size could be performed in the meta-analysis of overjet 
reduction by including only the top trial of Fig 3, which gave consistent results. 
 
4. Discussion 
4.1 | Summary of evidence 
The current systematic review summarizes evidence from 4 randomised trials on the clinical performance 
of PMAs for the treatment of children with (mostly Class II) malocclusion. The included trials moved on two 
major axes: comparison of PMAs to an untreated control group and comparison of PMAs to custom-made 
functional appliances. 
 As far as absolute effects of PMAs are concerned, some evidence about their efficacy was provided 
by a single trial from Norway (Myrlund et al., 2015). This indicated that PMAs provide clinically relevant 
dental effects consisting of overjet / overbite reduction, resolving of mandibular crowding and aid in 
establishing a Class I dental relationship at the canines. It seems that PMAs work mainly through protrusion 
/ proclination of the lower anterior teeth and increase in the face height, which explains the corrections in 
overjet, overbite, crowding, and partial correction of the dental relationship only at the canine, but not the 
molar, while they do not significantly influence the mandibular morphology or the ANB angle. This is to 
some degree similar to the effects of treatment with some functional appliances. However, functional 
appliances are known to produce more pronounced changes in the posterior dentition and also produce 
significant changes in the mandibular condyles, ramus, corpus, as well as the sagittal maxilla-mandibular 
relationship (through the ANB angle) (Lund and Sandler, 1998; Koretsi et al., 2015; Kyburz et al., 2019). 
To this basis, it is important to frame any clinical recommendations about the use of PMAs for early 
treatment on malocclusion, on trials that directly assess the efficacy of PMAs relative to custom-made 
functional appliances, whose performance has been meticulously documented with ample evidence in the 
previous decades. 
 When the clinical performance of PMAs is compared to custom-made functional appliances a 
different picture is evident. Custom-made functional appliances have significantly more pronounced and 
clinically relevant effects than PMAs in terms of overjet reduction, ANB angle reduction, increase in 
mandibular ramus height, nasolabial angle reduction and reduction in facial convexity. Furthermore, they 
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are more successful in establishing a solid Class I relationship at the molars than PMAs (45% versus 14%). 
The more favourable dentofacial picture witnessed after the use of functional appliances may due to the 
fact that they are custom-made appliances, which allow a precise anterior mandibular repositioning 
determined by the construction wax bite. Moreover, they are rigid appliances made of acrylic material which 
is harder than that of many PMAs like the Trainer, specifically the starting appliance (i.e. the soft blue 
trainer). The high elasticity of the T4K® PMA has been reported as an important flaw noted and reported 
by parents (Idris et al., 2018); this elasticity made it difficult for children to keep their mandibles in a forward 
position (i.e. in an edge-to-edge relationship at the incisors). 
 On the other hand, the report from a single trial shown evidence that PMAs have a clear advantage 
over custom-made functional appliances in terms of reduced number of treatment visits, chair-time and 
overall treatment costs. This is straightforward, since PMAs are prefabricated and ready to be inserted in 
the mouth or can be easily mouldable in warm water. 
 There are several factors that can influence the results of early orthodontic treatment with either 
PMAs or functional appliances. For example, patient compliance with instructions to wear a removable 
appliance has been directly linked to the attained results throughout treatment with removable appliances 
(Al-Kurwi et al., 2017). Patient compliance in terms of appliance wear might be checked qualitatively 
through interviews with the patient and treatment notes or checked quantitatively by dedicated 
microsensors embedded in the appliance (Schott and Ludwig, 2014), which have shown that most patients 
do not comply with given instructions for appliance wear time. However, criticisms about the accuracy us 
such sensors have been expressed (Brierley et al., 2017) and the exact amount of minimum wear time 
needed to produce adequate remains debatable (Parekh et al., 2019). In the present review, only two of 
the included trials assessed in any way patient compliance with appliance wear, but only through indirect 
means and this cannot be taken formally into account. 
 Another factor that might influence the diagnosis, choice of treatment, and outcome of early 
orthodontic treatment is the training, knowledge, and expertise of the treatment provider (Akyalcin, 2019). 
Orthodontists and orthodontic residents are certainly trained to make better judgements about case 
complexity compared to general dentists, based on objective severity indices, which indicates that 
additional orthodontic education has an influence on the ability to arrive to better assessment of the case 
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and diagnosis (Heath et al., 2017). Another study (Marques et al., 2012) indicated that 50% of general 
dentists would fail the American Board of Orthodontists objective outcome evaluation of a case they 
considered best representative of their clinical practice. Interceptive treatment for posterior crossbites, 
managed by orthodontic specialists, has been reported to achieve higher success rate and lower treatment 
costs compared to treatment by general dentists (Sollenius et al., 2019). This agrees with a previous study 
from Finland, which indicated that general dentists with little orthodontic experience usually overrate their 
provided orthodontic care to their patients (Pietilä et al., 1998). In the present review one trial employed 12 
general dentists for the early correction of Class II malocclusion with PMAs or functional appliances, but no 
information was given about systematic differences among the different trial centres or about the training, 
expertise, and calibration of the treatment providers, which might have influenced the trial’s results. 
 
4.2 | Strengths and limitations 
This systematic review has several strengths, which include its a priori registered protocol 
(https://osf.io/v3pjr/), its comprehensive literature search, the sole inclusion of randomised trials 
(Papageorgiou et al., 2015a; Papageorgiou et al., 2015b), the use of modern analytic methods (Langan et 
al., 2019), application of the GRADE approach to assess the strength of provided recommendations (Guyatt 
et al., 2011), and the transparent provision of all data (Papageorgiou and Cobourne, 2018; Papageorgiou 
et al., 2019a). Finally, this review builds up on the recommendation from a previous systematic review of 
randomised and non-randomised studies (Mohammed et al., 2019) that reported that PMAs were less 
effective in reducing overjet but had significantly less treatment costs. The current review retains the 
superiority of functional appliances for overjet reduction, but extends this further to additional various dental, 
skeletal, and soft-tissue effects. Therefore, concrete differences in the efficacy and mode of treatment were 
seen between PMAs and functional appliances, which potentially undermine the suggested advantage of 
reduced costs for PMAs. 
At the same time, some limitations also exist in the present review. First, both performed meta-
analyses were based predominantly on small trials, which might affect their results (Cappelleri et al., 1996; 
Papageorgiou et al., 2014). Second, most trials assessed treatment effects after 6-12 months of treatment 
and not on the long term, when any catch-up growth effects might be observed. Finally, the small number 
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of trials that were ultimately included in the meta-analyses and their poor reporting of potential confounders 
precluded the conduct of analyses for subgroups, meta-regressions, and reporting bias that were initially 
planned (Appendix 1). 
 
5. Conclusions 
The current systematic review summarizes evidence from 4 randomised trials with 232 patients on the 
clinical performance of PMAs for the treatment of children with (mostly Class II) malocclusion. According to 
evidence of moderate to low quality, the following can be concluded: 
▪ Compared to no treatment, PMAs seem to be effective in alleviating Class II malocclusion and 
mandibular crowding, which is mainly achieved through dentoalveolar effects (proclination of the 
lower incisors). 
▪ Compared to orthodontic treatment with functional appliances, PMAs are significantly less effective 
in treating Class II malocclusion through dentoalveolar effects and have significantly less potential 
to modify skeletal growth or improve the facial profile, even though they associated with significantly 
lower treatment costs. 
▪ Many of the claims made by manufacturers of PMAs about their clinical effect are unsubstantiated 
by up to date high quality evidence. 
▪ There is currently no evidence for the relative performance of the different PMAs or for any patient- 
or treatment-related factors that might influence treatment outcome. 
Therefore, even though PMAs might have some potentially beneficial characteristics, they cannot be 
suggested in an evidence-based manner as a regular early and solely treatment of malocclusion over 
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Fig 2. Contour-enhanced forest plot on the treatment effects of prefabricated myofunctional appliances versus functional appliances for change 





Fig 3. Contour-enhanced forest plot on the treatment effects of prefabricated myofunctional appliances versus functional appliances for change 
















Patients (M/F); age† Malocclusion / Tx Appliance Provide
r 







PMA: 57 (29/28); NR 
RFA: 40 (24/16); NR 
(overall age: 10.3) 
Class II/1; OJ>6mm or 
lip incompetence 
PMA: Myobrace® 
RFA: Activator (mod) 
GP Through 
discontinuati





T2: T1 + 
12 mos 
Casts: OB; OJ; sagMR 
Clinical: Chairtime; costs; 
LiSe; Re-Tx need; Tx 






PMA: 16 (9/7); 13.0 
RFA: 17 (8/9); 13.2 
Class II/1; OJ≥7mm PMA: T4F® 
RFA: Twin Block 
Ortho NR 6 mos LC: various skeletal, 






PMA: 26 (14/12); 10.3 
RFA: 28 (14/14); 10.6 
Class II/1; OJ>4mm; 
ANB>4°; Wits>2mm 
before/at growth spurt 
(HWR: PP2=, MP3=, S 
stages) 
PMA: T4K® + 
exercises 
RFA: Activator 
Ortho NR 12 mos LC: various skeletal, 






PMA: 25 (13/12); 7.7 
CTR: 23 (12/11); 7.7 
Class I or II with: 
(i) deepbite or (ii) 




CTR: No Tx  
Ortho From FU 
interview and 
patient notes 
12 mos Casts: OJ; OB; sagCR; 
sagMR; crowding‡ 
* countries given with their alpha-3 codes. 
† patient age is given either mean. 
‡ various skeletal, dental, and soft-tissue parameters were assessed from lateral cephalograms, but only in the PMA group, and are therefore not listed here. 
CTR, control group; FU, follow-up; GP, general practitioner; HWR, hand wrist radiograph; LC, lateral cephalogram; LiSe, lip seal; M/F, male / female; mo, month; mod, 
modified; NR, not reported; OB, overbite; OJ, overjet; Ortho, orthodontist or orthodontic resident under supervision of orthodontist; PMA, prefabricated myofunctional 
appliance; RCT, randomised clinical trial; RFA, removable functional appliance; sagCR, sagittal canine relationship; 

















Selection of the 
reported result 
Overall 
1 Cirgic 2016 Some concerns High Low High High High 
2 Hanoun 2010 Low  Low Low Low Some concerns Some concerns 
3 Idris 2018 Low Low Low High Some concerns High 
4 Myrlund 2015 Low  Low Low Low Some concerns Some concerns 
 
Table 3. Outcomes assessed by the single included trial comparing prefabricated myofunctional appliances with no treatment. 
Results pertain to post-treatment values, since no increments were given and not other similar trials were included to calculate 
pre/post correlations. 
Nr Trial Outcome Effect (95% CI) P  ½ SD Clinically relevant* 
1 Myrlund 2015 Overjet (mm) MD:-2.40 (-3.27, -1.53) <0.001 0.65 Yes 
2 Myrlund 2015 Overbite (mm) MD: -2.50 (-3.19, -1.81) <0.001 0.70 Yes 
3 Myrlund 2015 Class I molar relationship RR:1.53 (0.85,2.76) 0.16 - - 
4 Myrlund 2015 Class I canine relationship RR:2.29 (1.08, 4.85) 0.03 - Yes 
5 Myrlund 2015 Crowding (maxilla) RR:0.92 (0.55, 1.52) 0.74 - - 
6 Myrlund 2015 Crowding (mandible) RR:0.39 (0.18, 0.84) 0.02 - Yes 
CI, confidence interval; MD, mean difference; RR, relative risk; SD, standard deviation. 
* potentially clinically relevant effect, judged as an effect that is statistically significant (P<0.05) and its effect is at least as big 
as the minimal clinical important effect: half a standard deviation (combined pre-treatment standard deviation of the two 




Table 4. Results of the random-effects meta-analyses comparing prefabricated myofunctional appliances with functional appliances. Results pertain to treatment-
related reductions (increments) and positive MD indicate smaller reductions with prefabricated myofunctional appliances. 
Outcome Trials MD (95% CI) P I2 (95% CI) τ2 (95%CI) 95% PrI 
Overjet  3 1.50 (0.88, 2.11) <0.001* 0% (0%, 94%) 0 (0, 4.53) -2.48, 5.47 
Overbite 2 0.64 (-0.08, 1.36) 0.08 0% (0%, 98%) 0 (0, 17.43) - 
SNA 2 -0.11 (-0.66, 0.44) 0.70 0% (0%, 99%) 0 (0, 24.98) - 
SNB 2 -1.04 (-1.64, -0.43) 0.001* 0% (0%, 98%) 0 (0, 13.26) - 
ANB  2 0.91 (0.48, 1.35) <0.001* 0% (0%, 99%) 0 (0, 5.61) - 
SN-ML 2 0.16 (-0.68, 1.01) 0.70 0% (0%, 98%) 0 (0, 22.24) - 
NL-ML 2 0.53 (-0.39, 1.45) 0.26 0% (0%, 98%) 0 (0, 20.69) - 
N-Me 2 -1.73 (-4.91, 1.46) 0.29 77% (0%, 100%) 4.04 (0, 662.35) - 
ANS-Me 2 -1.39 (-2.50, -0.28) 0.01* 0% (0%, 98%) 0 (0, 33.04) - 
1s-NL 2 0.44 (-0.63, 1.50) 0.42 28% (0%, 99%) 0.24 (0, 108.84) - 
1i-ML 2 0.09 (-1.47, 1.64) 0.91 21% (0%, 99%) 0.31 (0, 189.01) - 
1s-1i 2 -0.84 (-3.38, 1.71) 0.52 0% (0%, 99%) 0 (0, 226.98) - 
CI, confidence interval; MD, mean difference. 




Table 5. Treatment-related changes assessed by single included studies. Omitted are the outcome of ANB angle and 
overjet, since they are included in the meta-analyses of Table 4. 
Nr Trial Outcome Effect (95% CI) P 
 
 ½ SD 
Clinically 
relevant* 
1 Cirgic 2016 Class I molar relationship RR:0.31 (0.15,0.65) 0.002    Yes 
2 Cirgic 2016 Number of visits MD:-3.05 (-4.60,-1.50) <0.001  2.05 Yes 
3 Cirgic 2016 Emergency visits MD:-0.60 (-0.90,-0.30) <0.001  0.45 Yes 
4 Cirgic 2016 Chair time (min) MD:-78.00 (-113.54,-42.46) <0.001  50.00 Yes 
5 Cirgic 2016 Direct costs—material MD:-152.00 (-175.57,-128.43) <0.001  37.50 Yes 
6 Cirgic 2016 Direct costs—chair time MD:-274.00 (-399.38,-148.62) <0.001  176.50 Yes 
7 Cirgic 2016 Indirect costs MD:-148.00 (-212.69,-83.31) <0.001  88.00 Yes 
8 Cirgic 2016 Societal (total) costs MD:-574.00 (-774.55,-373.45) <0.001  284.50 Yes 
9 Cirgic 2016 Treatment failure (residual overjet>3mm) RR:1.34 (0.95,1.88) 0.09   - 
10 Cirgic 2016 Retreatment need RR:1.64 (0.69,3.90) 0.27   - 
11 Cirgic 2016 Treatment duration MD:-2.64 (-5.77,0.49) 0.10   - 
12 Hanoun 2010 Ar-A (mm) MD:0.16 (-0.57,0.89) 0.67  1.74 - 
13 Hanoun 2010 Ar-B (mm) MD:-0.57 (-2.10,0.96) 0.46  2.49 - 
14 Hanoun 2010 Ar-Pog (mm) MD:-0.64 (-2.27,0.99) 0.44  2.73 - 
15 Hanoun 2010 Sella vertical-A (mm) MD:-0.47 (-1.29,0.35) 0.26  2.02 - 
16 Hanoun 2010 Sella vertical-Pog (mm) MD:-1.84 (-3.31,-0.37) 0.01  4.25 No 
17 Hanoun 2010 Lower/total anterior face height MD:-0.01 (-0.02, 0) 0.15  0.02 - 
18 Hanoun 2010 Sella vertical-1s (mm) MD:-0.74 (-1.92,0.44) 0.22  3.25 - 
19 Hanoun 2010 Sella vertical-1i (mm) MD:-2.56 (-3.96,-1.16) <0.001  2.96 No 
20 Idris 2018 N.A.Pog angle (°) MD:-1.48 (-2.69,-0.27) 0.02  2.31 No 
21 Idris 2018 S.N.Pog angle (°) MD:-0.61 (-1.26,0.04) 0.07   - 
22 Idris 2018 FH-MP angle (°) MD:1.01 (-0.12,2.14) 0.08   - 
23 Idris 2018 Y-axis angle (°) MD:0.38 (-0.43,1.19) 0.36   - 
24 Idris 2018 Ar-Go-Me angle (°) MD:-0.46 (-1.46,0.54) 0.37   - 
25 Idris 2018 Wits (mm) MD:0.63 (-0.49,1.75) 0.27   - 
26 Idris 2018 SN-NL angle (°) MD:-0.82 (-0.91,-0.74) <0.001  1.36 No 
27 Idris 2018 Cd-Gn (mm) MD:-1.44 (-3.76,0.88) 0.22   - 
28 Idris 2018 Go-Pog (mm) MD:-1.27 (-2.74,0.20) 0.09   - 
29 Idris 2018 Cd-Go (mm) MD:-2.18 (-2.85,-1.51) <0.001  2.18  Yes 
30 Idris 2018 N-ANS (mm) MD:-0.98 (-2.07,0.11) 0.08  2.29 - 
31 Idris 2018 ANS-PNS (mm) MD:-0.56 (-2.33,1.21) 0.54  2.15 - 
32 Idris 2018 1s-SN angle (°) MD:0.80 (-1.99,3.59) 0.57  4.19 - 
33 Idris 2018 Facial convexity angle (°) MD:-2.59 (-4.27,-0.91) 0.003  2.51 Yes 
34 Idris 2018 Nasolabial angle (°) MD:5.79 (0.82,10.76) 0.02  5.17 Yes 
35 Idris 2018 Mentolabial angle (°) MD:-5.52 (-12.86,1.82) 0.14  7.72 - 
36 Idris 2018 Ls-E line (mm) MD:-0.30 (-1.08,0.48) 0.45  0.72 - 
37 Idris 2018 Li-E line (mm) MD:0.14 (-0.65,0.93) 0.73  0.80 - 
CI, confidence interval; MD, mean difference; RR, relative risk; SD, standard deviation. 
* potentially clinically relevant effect, judged as an effect that is statistically significant (P<0.05) and its effect is at least as 
big as the minimal clinical important effect: half a standard deviation (combined pre-treatment standard deviation of the 
two groups) or relative risk ≥ 1.50 (or ≤0.67). 
  
29 









PMA Difference with PMAs 
Quality of the  
evidence (GRADE)b  
What happens with PMAs 
Overjet reduction [6 mos –Tx end] 
184 patients (3 trials) 
- 3.5 mm - 
1.5 mm less 
(0.9 to 2.1 less) 
 lowc 
due to bias 
Probably lead to smaller reduction 
in overjet 
Overbite reduction [6-12 mos] 
87 patients (2 trials) 
- 1.0 mm - 
0.6 mm less 
(1.4 less to 0.1 more) 
 moderated 
due to bias 
Little to no difference in overbite 
reduction 
Class I molar relationship [Tx end] 








(15.7% to 38.2% less) 
 moderated,e 
due to bias 
Probably lead to less patients with 
Class I molar relationship 
ANB reduction [6-12 mos] 
87 patients (2 trials) 
- 3.2 mm - 
1.3 mm less 
(0.6 to 2.0 less) 
 moderated 
due to bias 
Probably lead to smaller reduction 
in ANB angle 
Cd-Go increase [12 mos] 
54 patients (1 trial) 
- 2.7 mos - 
2.2 mm less 
(1.5 to 2.9 mm less) 
 moderated 
due to bias 
Probably lead to smaller vertical 
development of the ramus 
Facial convexity reduction [12 mos] 
54 patients (1 trial) 
- 4.0 °  - 
5.80 ° less 
(0.8 to 10.8 ° less) 
 moderated 
due to bias 
Probably lead more convex faces  
Total Tx costs [Tx end] 
97 patients (1 trial) 
- 1548 € - 574.0 € less (373.5 to 774.6 € less) 
 moderated,f 
due to bias 
Probably lead to higher treatment 
costs 
Interventions: Prefabricated myofunctional appliances (Myobrace®, T4F®, or T4K® with exercises) versus removable functional appliances (Activator, Twin 
Block) / Population: adolescent patients with any kind of malocclusion / Setting: private practices and university clinics (Malaysia, Sweden, Syria). 
a Response in the control group is based on average response of included studies (random-effects meta-analysis). 
b Starts from "high" 
c Downgraded by two levels for bias due to multiple methodological issues. 
d Downgraded by one level for bias due to methodological issues. 
e Potentially large effect observed (RR<0.5), but no upgrading due to residual confounding. 
f Potentially large effect observed (RR<0.5), but no upgrading due to residual confounding. 
CI, confidence interval; GRADE, Grading of Recommendations Assessment, Development and Evaluation; mo, month; PMA, prefabricated myofunctional 






Appendix 1. Additional review details and deviations from protocol. 
 
Communications with trialists 
▪ Dr. A.A. Hanoun was contacted on July 23rd, 2019 to request a full-text of his MSc thesis so it can 
be formally included in the review, since only a preview pdf could be acquired. The same was 
requested from the thesis supervisor Dr. N. Mokhtar, after Dr. Hanoun suggested so. The full text 
of the unpublished thesis was ultimately provided via e-mail on August 12th. 
▪ Dr. E. Cirgic was contacted on July 25th, 2019 to request missing data (age, overbite changes, lip 
seal changes) and outcome data for either a common timepoint between groups or estimates 
adjusted for treatment duration (either as aggregate data or the trial’s dataset). No response has 
yet been received. 
 
Additional methods 
▪ We back-calculated Pre/Post correlation for change in overjet in the PMA group (0.59) and the 
functional appliance group (0.40) from the Idris 2018 trial that provided both before-and-after data, 
as well as increments. These Pre/Post correlations were used to calculate overjet increments for 
the Cirgic 2016 trial. 
 
Deviations from protocol 
▪ We planned to calculate 95% random-effects predictions for all meta-analyses with ≥3 trials to aid 
in their interpretations, but only 2 meta-analyses with 2 trials each were ultimately performed. 
▪ Several factors were planned to be assessed through subgroup analyses/meta-regressions in 
meta-analyses of at least 5 studies, but could ultimately not be conducted due to limited 
material/reporting: (i) subsets according to the patient characteristics (patient chronological age, 
skeletal age, sex, ethnicity, craniofacial configuration, masticatory activity, jaw, baseline 
malocclusion severity), (ii) subsets according to the different experimental interventions (different 
31 
experimental or control appliances), (iii) subset according to any co-interventions administered, (iv) 
subsets according to the inclusion of tooth extractions in the treatment plan, and (v) subsets to the 
treatment provider, including experience each system and status (orthodontist / general dentist). 
▪ We planned to set a significance level of 10% for tests of between-studies or between-subgroups 




Appendix 2. Literature search strategies for each database, including hits (as of July 25th, 2019). 
Database Search Limits Hits 
MEDLINE 
"prefabricated myofunctional appliance" OR "prefabricated 
myofunctional appliances" OR "pre-fabricated myofunctional 
appliance" OR "pre-fabricated myofunctional appliances" OR 
"prefabricated functional appliance" OR "prefabricated functional 
appliances" OR "pre-fabricated functional appliance" OR "pre-
fabricated functional appliances" OR "eruption guidance" OR 
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Appendix 4. Detailed assessment of included randomised trials with the RoB 2.0 tool (supplement to Table 2). 
Domain Reference Cirgic 2015 Hanoun 2010 Idris 2018 Myrlund 2015 
1. Randomisation 
process 
1.1 PY Y Y Y 
1.2 PY Y Y Y 
1.3 PY N N PN 




2.1 Y Y Y Y 
2.2 Y Y Y Y 
2.3 PY PN PN PN 
2.4 PY NA NA NA 
2.5 PN NA NA NA 
2.6 PY Y Y Y 
2.7 NA NA NA NA 
Judgement High Low Low Low 
3. Mising 
outcome data 
3.1 Y PN PY PY 
3.2 NA PY NA NA 
3.3 NA NA NA NA 
3.4 NA NA NA NA 
Judgement Low Low Low Low 
4. Measurement 
of the outcome 
4.1 N N N N 
4.2 PN N N PN 
4.3 Y N PY N 
4.4 PY NA PY NA 
4.5 PY NA NI NA 
Judgement High Low High Low 
5. Selection of 
the reported 
result 
5.1 NI NI NI NI 
5.2 PY PN N N 
5.3 Y PN N N 
Judgement High Some concerns Some concerns Some concerns 
Overall Judgement High Some concerns High Some concerns 
  
  
  
 
 
